{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:03:46Z","timestamp":1793030626947,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jtho.2024.12.014","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T07:42:58Z","timestamp":1736322178000},"page":"262-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Perspective on the MARS2 Trial"],"prefix":"10.1016","volume":"20","author":[{"given":"Eric","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavitt","family":"Woodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jablons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2024.12.014_bib1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtho.2024.12.014_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02114-2023","article-title":"A\u00a0randomised phase II study of extended pleurectomy\/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205","volume":"63","author":"Raskin","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtho.2024.12.014_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.21037\/atm.2017.04.05","article-title":"Randomized controlled trials in malignant pleural mesothelioma surgery-mistakes made and lessons learned","volume":"5","author":"Waller","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jtho.2024.12.014_bib7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jtcvs.2022.01.054","article-title":"Outcomes of pleurectomy decortication in patients with biphasic mesothelioma","volume":"164","author":"Lapidot","year":"2022","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"33","author":"Popat","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038892","article-title":"Mesothelioma and radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma","volume":"10","author":"Lim","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtho.2024.12.014_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13037-016-0117-6","article-title":"Why do surgeons continue to perform unnecessary surgery?","volume":"11","author":"Stahel","year":"2017","journal-title":"Patient Saf Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejcts\/ezaa158","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"58","author":"Opitz","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.semtcvs.2009.06.011","article-title":"Current trends in radiologic management of malignant pleural mesothelioma","volume":"21","author":"Gill","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00330-024-10963-6","article-title":"Are there features that can predict the unresectability of pleural mesothelioma?","volume":"35","author":"Mayoral","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jtho.2024.12.014_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jnci\/djx175","article-title":"Quantitative clinical staging for patients with malignant pleural mesothelioma","volume":"110","author":"Gill","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2024.12.014_bib16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jtho.2024.03.007","article-title":"The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the \u201cT\u201d Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma","volume":"19","author":"Gill","year":"2024","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jtho.2016.04.027","article-title":"North American multicenter volumetric CT study for clinical staging of malignant pleural mesothelioma: feasibility and logistics of setting up a quantitative imaging study","volume":"11","author":"Gill","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01243894-200602000-00014","article-title":"Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma","volume":"1","author":"Sugarbaker","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/JTO.0b013e3181dd0ef1","article-title":"Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans","volume":"5","author":"Liu","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/SLA.0000000000004306","article-title":"Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging results and novel prognostic implications based on experience in 355 consecutive patients","volume":"275","author":"Lapidot","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib21","doi-asserted-by":"crossref","unstructured":"Opitz I, Lauk O, Werner R, et al. Characteristics of long-term survivors with malignant pleural mesothelioma. Ann Thorac Surg. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.10.004, accessed November 10, 2024.","DOI":"10.1016\/j.athoracsur.2024.10.004"},{"key":"10.1016\/j.jtho.2024.12.014_bib22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jtho.2024.01.018","article-title":"The International Association for the Study of Lung Cancer pleural mesothelioma staging project: expanded database to inform revisions in the ninth edition of the TNM classification of pleural mesothelioma","volume":"19","author":"Wolf","year":"2024","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jtho.2024.12.014_bib24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jtho.2021.06.014","article-title":"Mesothelioma risk score: a new prognostic pretreatment, clinical-molecular algorithm for malignant pleural mesothelioma","volume":"16","author":"Yeap","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2024.12.014_bib26","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/JTO.0000000000000661","article-title":"A\u00a0new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma: a review of 12 years\u2019 experience","volume":"10","author":"Opitz","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1470-2045(20)30462-9","article-title":"Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in","volume":"21","author":"Nowak","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2017.05.012","article-title":"Cost-effectiveness analysis of additional bevacizumab to pemetrexed plus cisplatin for malignant pleural mesothelioma based on the MAPS trial","volume":"110","author":"Zhan","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.12.014_bib29","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jtho.2023.06.011","article-title":"European epidemiology of pleural mesothelioma-real-life data from a joint analysis of the Mesoscape database of the European thoracic oncology platform and the European society of thoracic surgery mesothelioma database","volume":"18","author":"Opitz","year":"2023","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib31","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.21037\/tlcr-22-199","article-title":"Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach","volume":"11","author":"Klotz","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2024.12.014_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.surg.2019.08.023","article-title":"Acquiring and maintaining lifelong expertise in surgery","volume":"167","author":"Sachdeva","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.jtho.2024.12.014_bib33","doi-asserted-by":"crossref","first-page":"E594","DOI":"10.1503\/cjs.008520","article-title":"Expertise-based design in surgical trials: a narrative review","volume":"64","author":"Alsagheir","year":"2021","journal-title":"Can J Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib34","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jtho.2018.08.001","article-title":"Surgery in malignant pleural mesothelioma","volume":"13","author":"Bueno","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtcvs.2014.03.011","article-title":"Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality","volume":"148","author":"Burt","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/icvts\/ivw422","article-title":"Propensity matched comparison of extrapleural pneumonectomy and pleurectomy\/decortication for mesothelioma patients","volume":"24","author":"Kostron","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib38","first-page":"3607","article-title":"Prolonged post-recurrence survival following pleurectomy\/decortication for malignant pleural mesothelioma","volume":"17","author":"Kai","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2024.12.014_bib39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00595-021-02437-9","article-title":"Surgical strategy for malignant pleural mesothelioma: the superiority of pleurectomy\/decortication","volume":"52","author":"Kanayama","year":"2022","journal-title":"Surg Today"},{"key":"10.1016\/j.jtho.2024.12.014_bib40","first-page":"5544","article-title":"Systematic Review and Meta-Analysis of pleurectomy\/decortication versus extrapleural Pneumonectomy in the Treatment of Malignant Pleural mesothelioma","volume":"11","author":"Danuzzo","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtho.2024.12.014_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.athoracsur.2024.02.022","article-title":"Impact of operation on disease progression and survival of patients with pleural mesothelioma","volume":"118","author":"Nakamura","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01243894-200605000-00004","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial","volume":"1","author":"Flores","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib43","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.athoracsur.2014.05.071","article-title":"Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions","volume":"98","author":"Lauk","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib44","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib45","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jtcvs.2021.07.017","article-title":"Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma","volume":"163","author":"Hasegawa","year":"2022","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib46","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2024.12.014_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1470-2045(20)30606-9","article-title":"Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial","volume":"22","author":"Cho","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11010","article-title":"Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation","volume":"11","author":"Dundar","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jtho.2024.12.014_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190257","article-title":"Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: health economic analysis of the SMART trial","volume":"13","author":"Stewart","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2024.12.014_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107440","article-title":"Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma","volume":"187","author":"Dumoulin","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.12.014_bib51","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jtho.2023.11.014","article-title":"Brief report: real-world toxicity and survival of combination immunotherapy in pleural mesothelioma-RIOMeso","volume":"19","author":"McNamee","year":"2024","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.12.014_bib52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086424025334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086424025334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:37:25Z","timestamp":1772325445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086424025334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1556086424025334"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2024.12.014","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Perspective on the MARS2 Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2024.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}